Voleon Capital Management’s Arbutus Biopharma ABUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,741
Closed -$94.8K – 775
2026
Q2
$94.8K Buy
+19,741
New +$86.7K ﹤0.01% 749
2026
Q1
– Sell
-16,387
Closed -$78.8K – 781
2025
Q4
$78.8K Buy
16,387
+5,984
+58% +$26.9K ﹤0.01% 758
2025
Q3
$47.2K Buy
+10,403
New +$38.2K ﹤0.01% 873

Other funds holding ABUS

Voleon Capital Management's ABUS Position: Q3 2026 in Review

Voleon Capital Management sold out of Arbutus Biopharma (ABUS) in Q3 2026, closing a stake of 19,741 shares — an estimated $94.8K sold.

Voleon Capital Management first reported a position in ABUS in Q3 2025 and held it in 3 quarters. The position peaked at $94.8K in Q2 2026. 216 funds tracked by Wall St. Rank hold ABUS as of Q3 2026.

  • Voleon Capital Management reported no remaining Arbutus Biopharma position as of Q3 2026 after selling out during the quarter.
  • Voleon Capital Management sold 19,741 Arbutus Biopharma shares in Q3 2026, an estimated $94.8K.
  • Voleon Capital Management first reported a position in Arbutus Biopharma in Q3 2025 and held it in 3 quarters.
  • Voleon Capital Management's Arbutus Biopharma position peaked at $94.8K in Q2 2026.
  • 216 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q3 2026.

Based on Voleon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.